EFLM Working Group Accreditation and ISO/CEN standards on dealing with ISO 15189 demands for retention of documents and examination objects.

EFLM ISO 15189 failure-mode-effects-analysis (FMEA) quality management retention time risk assessment

Journal

Advances in laboratory medicine
ISSN: 2628-491X
Titre abrégé: Adv Lab Med
Pays: Germany
ID NLM: 9918284273306676

Informations de publication

Date de publication:
Jun 2024
Historique:
received: 18 05 2023
accepted: 07 01 2024
medline: 28 6 2024
pubmed: 28 6 2024
entrez: 28 6 2024
Statut: epublish

Résumé

Many aspects of the activity of a medical laboratory have to be documented so as to facilitate the maintenance of the ongoing quality of service. As a consequence, many documents, forms and reports are generated. The retention time for each of these has to be specified. In addition to medical laboratory reports as part of the patient's medical record, the medical laboratory has to retain many documents and specimens according to national legislation or guidance from professional organizations, if these exist. If not, the laboratory management needs to define a retention schedule, which shall define the storage conditions and period of storage, according to ISO 15189:2022 requirements for retention of general quality management documents and records. The EFLM Working Group on Accreditation and ISO/CEN standards provides here a proposal on retention periods of documentation and specimens based on a failure-mode-effects-analysis (FMEA) risk-based approach, a concept of risk reduction that has become an integral part of modern standards.

Identifiants

pubmed: 38939196
doi: 10.1515/almed-2023-0053
pii: almed-2023-0053
pmc: PMC11206180
doi:

Types de publication

Journal Article

Langues

eng

Pagination

103-108

Informations de copyright

© 2024 the author(s), published by De Gruyter, Berlin/Boston.

Déclaration de conflit d'intérêts

Competing interests: The authors state no conflict of interest.

Auteurs

Pika Meško Brguljan (P)

University Clinic for Respiratory and Allergic Diseases, Golnik, Slovenia.

Marc H M Thelen (MHM)

Department of Laboratory Medicine, Radboud University Medical Centre, Nijmegen, the Netherlands.
Foundation for Quality Assurance in Laboratory Medicine (SKML), Nijmegen, the Netherlands.

Francisco A Bernabeu-Andreu (FA)

Servicio de Análisis Clinicos - H.U. Puerta de Hierro Majadahonda, Madrid, Spain.

Christos Kroupis (C)

Department of Clinical Biochemistry, Attikon University General Hospital, Medical School, National and Kapodistrian University of Athens, Haidari, Greece.

Guilaine Boursier (G)

Department of Genetics, Rare Diseases and Personalized Medicine, CHU Montpellier, Univ Montpellier Montpellier, France.

Ines Vukasović (I)

Department of Clinical Chemistry, Sestre Milosrdnice University Hospital Center Zagreb, Croatia.

Edward Barrett (E)

Consultant Clinical Biochemist, Limerick, Ireland.

Duilio Brugnoni (D)

Clinical Chemistry Laboratory - Spedali Civili, Brescia, Italy.

Maria Lohmander (M)

Laboratoriemedicin NU-Sjukvården Trollhättan, Sweden.

Luděk Šprongl (L)

Clinical Laboratory, Hospital Kladno Kladno, Czech Republic.

Tatjana Vodnik (T)

Center of Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia.

Irina Ghiţă (I)

Synevo Central Lab Clinical Trials, Iflov County, Chiajna, Romania.

Florent Vanstapel (F)

Laboratory Medicine, University Hospital Leuven, Leuven, Belgium.
Department of Public Health, Biomedical Sciences Group, Catholic University Leuven, Leuven, Belgium.

Michel Vaubourdolle (M)

Département de Biochimie, Hôpital Saint-Antoine - AH-HP, Paris, France.

Willem Huisman (W)

Consultant European Specialist in Clinical Chemistry and Laboratory Medicine, The Hague, the Netherlands.

Classifications MeSH